102 related articles for article (PubMed ID: 35411579)
1. Bioequivalence of two oral formulations of tebipenem pivoxil hydrobromide in healthy subjects.
Gupta VK; Patel G; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
Clin Transl Sci; 2022 Jul; 15(7):1654-1663. PubMed ID: 35411579
[TBL] [Abstract][Full Text] [Related]
2. Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects.
Patel G; Gupta VK; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0149522. PubMed ID: 36943038
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects.
Gupta VK; Maier G; Eckburg P; Morelli L; Lei Y; Jain A; Manyak E; Melnick D
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0014521. PubMed ID: 33875429
[TBL] [Abstract][Full Text] [Related]
4. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal Impairment.
Patel G; Rodvold KA; Gupta VK; Bruss J; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
Antimicrob Agents Chemother; 2022 May; 66(5):e0240721. PubMed ID: 35420493
[TBL] [Abstract][Full Text] [Related]
6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
7. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
[TBL] [Abstract][Full Text] [Related]
8. Absorption, Metabolism, and Excretion of [
Gupta VK; Maier G; Gasink L; Ek A; Fudeman M; Srivastava P; Talley A
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0150922. PubMed ID: 36995239
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations: a randomized-sequence, open-label, two-period crossover study in healthy Chinese adult male volunteers.
Zou J; Di B; Wu CY; Hu Q; Li JH; Zhu Y; Fan H; Xiao D; Wang GJ
Clin Ther; 2008 Apr; 30(4):654-60. PubMed ID: 18498914
[TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding.
Fouad A; Quintiliani R; Nicolau DP; Asempa TE
J Antimicrob Chemother; 2022 Dec; 78(1):205-208. PubMed ID: 36374528
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
13. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang
Sun ML; Liu HJ; Luo XD; Wang Y; Zhang W; Liu C; Wang X
Drugs R D; 2022 Mar; 22(1):51-60. PubMed ID: 35061235
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects.
Almeida S; Filipe A; Neves R; Spínola AC; Tanguay M; Ortuño J; Farré A; Torns A
Clin Ther; 2010 Mar; 32(3):556-74. PubMed ID: 20399993
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study.
Sádaba B; Azanza JR; García-Bea A; Labeaga L; Campo C; Valiente R
Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):265-272. PubMed ID: 31820304
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]